Health
Pfizer, BioNTech propose expanding Covid-19 vaccine trial to 44,000 volunteers – Hindustan Times
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
Pfizer Inc and BioNTech SE on Saturday proposed to the US Food and Drug Administration (FDA) to expand their Phase 3 pivotal Covid-19 vaccine trial to about 44,000 participants while increasing the diversity of the trial population.
The initial target figure for the trial was up to 30,000 participants, which the companies said they expect to reach by next week.
The proposed expansion would also allow the companies to enroll people as young as 16 and people with chronic, stable HIV, hepatitis C…
-
Noosa News24 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales